Inhibitory effect of melatonin on homocysteine-induced lipid peroxidation in rat brain homogenates

Pharmacology and Toxicology

Volumn 90, Issue 1, 2002, Pages 32-37

  Osuna, Carmen ^a,b   Reiter, Russel J ^a   García, Joaquin J ^a   Karbownik, Malgorzata ^a   Tan, Dun Xian ^a   Calvo, Juan R ^a,b   Manchester, Lucien C ^a  

^a University of Texas Health Science Center at San Antonio   (United States)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALKENE DERIVATIVE; ANTIOXIDANT; HOMOCYSTEINE; MALONALDEHYDE; MELATONIN;

ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BIOACCUMULATION; BRAIN HOMOGENATE; BRAIN INJURY; BRAIN PROTECTION; CARDIOVASCULAR DISEASE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RISK FACTOR; TISSUE LEVEL;

ANIMALS; ANTIOXIDANTS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HOMOCYSTEINE; LIPID PEROXIDATION; MALE; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0036178331     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.900107.x     Document Type: Article

References (54)

1. Characterization of high-affinity melatonin binding sites in purified cell nuclei of rat liver
2. Calmodulin mediates cytoskeletal effects
3. Calmodulin and protein kinase C are two Ca2+-binding proteins that mediate intracellular melatonin signaling
4. Physiological levels of melatonin contribute to the antioxidant capacity of human serum
5. Oxidative stress: Its role in the pathogenesis of amyotrophic lateral sclerosis
6. A rapid and sensitive method for quantification of protein utilizing the principle of protein dye binding
7. Melatonin reduces oxidative neurotoxicity due to quinolinic acid: In vitro and in vivo findings
8. The biology of oxygen radicals
9. Melatonin enhances tamoxifen's ability to prevent the reduction in microsomal membrane fluidity induced by lipid peroxidation
10. Melatonin enhances IL-2, IL-6, and IFN-production by human circulating CD4+ cells
11. Signal transduction for melatonin in human lymphocytes
12. High affinity binding of melatonin by human circulating T lymphocytes (CD4+)
13. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation
14. Superoxide mediated oxidation of low-density lipoproteins by thiols
15. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells
16. Effects on the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-/) in culture
17. Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemia in rats
18. DNA damage and oxygen radical toxicity
19. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats
20. Oxidative stress as a cause of Parkinson's disease
21. In vitro melatonin treatment enhances cell-mediated immune function in male prairie voles (Microtus ochrogaster)
22. Anticonvulsant activity of melatonin against seizures induced by quinoleate, kainate glutamate, NMDA, and pentylenetetrazole in mice
23. The oxidant stress of hyperhomocyst(e)inemia
24. The immunoendocrine role of melatonin
25. Increased brain damage after stroke or exitoxic seizures in melatonin deficient rats
26. Homocysteine and coronary atherosclerosis
27. Melatonin reduces kainate-induced lipid peroxidation in homogenates of different brain regions
28. Nuclear localization of melatonin in different mammalian tissues: Immunocytochemical and radioimmunoassay evidence
29. Protective effect of melatonin in a model of traumatic brain injury in mice
30. Homocysteine thiolactone: Failure to detect in human serum or plasma
31. The effects of oral melatonin on skin color and on the release of pituitary hormones
32. Protective effect of melatonin against homocysteine-induced vasoconstriction of human umbilical artery
33. Melatonin suppresses homocysteine enhancement of serotonin-induced vasoconstriction of the human umbilical artery
34. An assessment of the antioxidant and antiamyloidogenic properties of melatonin: Implications for Alzheimer's disease
35. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin
36. Pineal melatonin: Cell biology of its synthesis and of its physiological interactions
37. The aging pineal gland and its physiological consequences
38. Oxidative processes and antioxidative defense mechanisms in the aging brain
39. Aging and oxygen toxicity: Relation to changes in melatonin
40. Oxidative damage in the central nervous system: Protection by melatonin
41. Melatonin: Lowering the high price of free radicals
42. Transition metals, ferritin, gluthatione and ascorbic acid in Parkinsonian brains
43. Membrane-bound calmodulin in X. Laevis oocytes as a novel binding site for melatonin
44. Homocysteine metabolism
45. 2-induced lipid peroxidation in homogenates of different rat brain regions
46. Neural tube defects and elevated homocysteine levels in amniotic fluid
47. Melatonin: A potent endogenous hydroxyl radical scavenger
48. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo
49. Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice
50. Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain
51. Homocyst(e)ine-induced endothelial cell injury in vitro: A model for the study of vascular injury
52. Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer
53. Antagonistic effect of melatonin against cyanide-induced seizures and acute lethality in mice
54. Melatonin attenuates l-cysteine-induced seizures and lipid peroxidation in the brain of mice